Biotech
Madrid Promotes Digital Telecare for the Elderly with 10 Million
The objective of advanced home telecare is to improve the quality of life of the elderly, ensuring intervention when they have a personal, social, or medical need to guarantee their safety and prolong their stay in their homes as much as possible in the face of alternatives such as day centers or residences. The beneficiaries of this new model, with European funds, will also have a home habit detector.
Madrid ups the ante for telecare for seniors. The Government of the Community of Madrid has awarded the latest contract for €10 million to acquire digital terminals and advanced telecare devices for elderly dependents.
The total investment for this program, which will involve the acquisition of 310,000 devices, exceeds €39 million, according to the Community Executive in a statement.
This technology will make it possible to replace the current analog home telecare systems with digital sensor systems, among which there will be mobility detectors that will make it possible to control the activity or inactivity of a person, falls, medication dispensers, or magnetic witnesses to know if they open or no doors to the house or the ignition of electrical appliances.
The renovation will affect the 179 municipalities in the region and will adapt the service to the needs of the 94,000 users with some type of dependency who will benefit from it, compared to the 65,000 who now enjoy the traditional red button that has been in operation since the 1990s.
Read more about the investment in telecare and find other interesting financial news with our companion app Born2Invest.
Madrid invests in telecare and renews technological devices for 94,000 users in the region
The objective of advanced home telecare is to improve the quality of life of the elderly, ensuring intervention when they have a personal, social, or medical need to guarantee their safety and prolong their stay in their homes as much as possible in the face of alternatives such as day centers or residences.
The beneficiaries of this new model of telecare in the Community of Madrid, with European funds, will also have a home habit detector. Through the measurement of values related to humidity, temperature, light, or electricity consumption, they will configure their life pattern with their daily routines (sleep, meals, exits, and entrances). Unusual activities or deviations from those routines will automatically generate an alert in the control center, as they may be indicators of a risk situation.
Precisely, a few weeks ago, the Government of the Community of Madrid announced the investment of €7.6 million in the extension of two contracts for public residences for the elderly. The Villa el Padro center will offer 120 residential spaces and 40-day centers, while the Plata y Castañar center, located in the capital city, will have 220 residential spaces and 45-day shifts.
The day centers of the health residences will be of a socio-rehabilitation nature and day stay for the elderly with reduced autonomy. The doctors and nurses will develop a gerontological and rehabilitative activity that includes the actions of preventive and care medicine, as well as psychological guidance with the diagnosis.
__
(Featured image by truthseeker08 via Pixabay)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in PlantaDoce, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
-
Biotech2 weeks ago
Vytrus Biotech Reports Its Best Quarter: Record Revenue and Rising EBITDA
-
Cannabis4 days ago
Legal Sale of Cannabis in Germany: Pilot Projects in Frankfurt and Hanover
-
Biotech1 week ago
Dijon Biotech Company Inventiva Raises 348 Million to Complete Its Phase III
-
Markets3 days ago
Spanish Companies Welcome the End of Trade Restrictions with Algeria with Relief and Caution